A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group - Wikidata - wikimedia - TriplyDB

A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group

A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group

http://www.wikidata.org/entity/Q35533708

about

Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease Tiotropium for stable chronic obstructive pulmonary disease Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.Tiotropium (Spiriva): a once-daily inhaled anticholinergic medication for chronic obstructive pulmonary disease Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease.Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease * 12: New treatments for COPD Underdiagnosed asthma in South Australia.Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease.Pharmacologic treatment of chronic obstructive pulmonary disease: past, present, and future.Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial.Profile of a fixed-dose combination of tiotropium/olodaterol and its potential in the treatment of COPD.Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease.Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.A randomized multicenter Phase II study of perioperative tiotropium intervention in gastric cancer patients with chronic obstructive pulmonary disease.Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial.Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey Chronic obstructive pulmonary disease: the evidence for use of tiotropium.The Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.Combination inhaled bronchodilator therapy in the management of chronic obstructive pulmonary disease.COPD--the primary care perspective: addressing epidemiology, pathology, diagnosis, treatment of smoking's multiple morbidities and the patient's perspective.Pharmacotherapies for COPD.Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.Treatment persistence and compliance with medications for chronic obstructive pulmonary disease The combination of tiotropium and budesonide in the treatment of chronic obstructive pulmonary disease.Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.Efficacy of tiotropium in the prevention of exacerbations of COPD.Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.The Saudi Guidelines for the Diagnosis and Management of COPD.Tiotropium bromide for chronic obstructive pulmonary disease.Indacaterol: pharmacologic profile, efficacy and safety in the treatment of adults with COPD.NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease.Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease.Do we know the minimal clinically important difference (MCID) for COPD exacerbations?What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease?Once-daily glycopyrronium via the Breezhaler® device for the treatment of COPD: pharmacological and clinical profile.

P2860

Q24187073-5735D513-749E-4515-9F5A-F5AF9F4EB771 Q24198068-6C615DB3-E831-4E4E-BA96-53C650519794 Q24246991-CA31E321-BF11-4713-9D46-9EB0A57506C9 Q27348844-EF7E0DD6-2269-4FF8-80C9-ADF14C393EF0 Q33944981-37B494A0-AD66-46D5-842C-7B0DEC0A8DBC Q34177358-33D016E3-329F-4F9B-B0AB-E9A40D90765A Q34944616-3260A625-B281-44B7-A6D1-B8BE2F8AA103 Q35205369-7A51C4A3-3E97-42E9-A70D-3C60419160CA Q35208742-FE82FC50-8042-4545-BDCF-958829FFAFEB Q35535482-16576653-2214-4AE4-98D1-DEF676CD73C7 Q35535487-E2F56BCD-F851-4854-8DB6-FFD53616EAA8 Q35574022-C61A1519-0D3D-4C0C-B76E-85375865AD97 Q35695190-27036A5D-0E84-4D4E-85BE-07ABB71E0922 Q35766346-9A4FFE9B-17C6-4D7C-BF94-6865A482A3AE Q35766357-C9E790B3-928A-4606-8428-E1493A4CD602 Q35841607-1BCAF3B6-06AA-4CF7-900B-F8C2A7BDE725 Q36170545-7EB61896-32A2-4A36-914F-EDA1D279F5DE Q36184259-54DE7DEA-F680-4CA8-91CD-C86C89109856 Q36196805-F40FDEE8-6A5C-44F9-B1F1-46A3F3B98582 Q36200675-7E7B3EEE-4E16-4434-B2B2-5181CD0450DC Q36390663-9BCC68EC-3D59-4CEA-8CE4-757905E1C4CF Q36405313-447EDF2A-8A9D-45B8-85CB-BCD56A4142E0 Q36566081-4CBBA6D9-BE81-4F75-852B-811FAFB129A5 Q36742419-4624EDA1-A811-4DE9-9B58-D607A36352AB Q36761477-96B78B74-12E4-4E83-9431-74DF22C641DF Q36843717-DCF00FF1-5B8C-4256-B0CE-7DF4F70FD2EB Q37177278-87A2C74C-6109-4F9C-B0AC-1A251A3BD41C Q37212357-BF961173-2116-4B78-AAFA-BF2B5BE159A4 Q37221196-CF9EC4F1-5430-4C86-B2CF-F8BE82686B20 Q37310689-6858E561-9692-4EDE-B4B2-4D04F4F04A9A Q37555782-F8B069F3-00CB-4CDB-A0C1-1ACA726A83A8 Q37667100-439340FA-C629-4ED3-88C0-A250C833F083 Q37733309-69081A2C-2D66-486B-89E2-38D5319BD1A3 Q37755016-85D143B1-66BD-4A14-9BED-BD9B4BFF9E6C Q37846698-97A69FA9-BDE4-43E6-A57B-277190993CAE Q37867838-ED43AC1B-F949-4A1B-9E17-2510697903BD Q37973132-245266DC-56D3-45CB-8783-8AF3812A5BF9 Q38091512-412B2C2D-D115-4F99-9422-22787F44469B Q38095562-47D1C6E1-71D7-43B2-B7BD-3C8FE54E2B94 Q38131050-C9654311-DE01-48EA-9209-40855F512494

P2860

A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group

http://www.wikidata.org/entity/Q35533708

description

2000 nî lūn-bûn

@nan

2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

A randomised controlled compar ...... e Dutch Tiotropium Study Group

@ast

A randomised controlled compar ...... e Dutch Tiotropium Study Group

@en

type

label

A randomised controlled compar ...... e Dutch Tiotropium Study Group

@ast

A randomised controlled compar ...... e Dutch Tiotropium Study Group

@en

prefLabel

A randomised controlled compar ...... e Dutch Tiotropium Study Group

@ast

A randomised controlled compar ...... e Dutch Tiotropium Study Group

@en

P1433

Q35533708-DAC4F50E-6280-4F21-AA48-653F5259E647

P1476

Q35533708-21D87495-64A9-44A1-BC79-CC74F5DA59A8

P2093

Q35533708-0D3CE3A9-965B-4732-82C6-FB3D3AD342E9

Q35533708-22AEAE10-1B0D-4EBF-8CA4-7CDD0AF4CF24

Q35533708-6B0E26C0-16D7-489E-8E2D-6A2589E9CE54

Q35533708-81E60812-366E-43B7-AAB5-FBB1BFED752E

Q35533708-DDACFDF7-6237-49F5-9981-0CDCA6390FB2

P2860

Q35533708-1783E5B4-5493-4E33-8735-C4C455D65574

Q35533708-25A68B9E-65D9-455A-9F81-97DCCDDAA694

Q35533708-2F3944F7-F4CB-4439-940F-CA8D926472E6

Q35533708-59FFF9B7-B2CD-4F62-B99F-4A69FE032529

Q35533708-5F47DA39-D937-4EE1-A03C-7FA8E896E02D

Q35533708-7D6347AE-0FEA-4009-B8C7-3FA84DABA799

Q35533708-A464352D-0320-40D0-8739-4AECCA371C72

Q35533708-C2EA1D53-4894-4889-A890-72A5F2DEF243

Q35533708-EAB3FAEB-9CF9-49FB-8A8E-07AF90CA7EF8

Q35533708-ED65BC41-80F5-49A1-81DE-0A84010CB535

P304

Q35533708-8430947E-D71B-4F25-88BE-935897962FCB

P31

Q35533708-C3FF3E09-9BB0-4A7E-A291-7FD6B444EE81

P356

Q35533708-64D7CDE4-F3A4-4C06-A744-62642A62E88B

P407

Q35533708-685B553B-F6B0-4CA3-ADBA-CF531684E386

P433

Q35533708-AE1E4BAB-3458-41AB-8E6B-15F7448C1093

P478

Q35533708-2534B7B9-E39B-4A1D-AA56-B5C0FE014563

P577

Q35533708-3AB44F0D-4118-4782-BB51-902EAB6F1EAD

P698

Q35533708-8D687A25-0549-4C3D-84FA-58F79C6AC1B3

P921

Q35533708-05DF218C-4D34-4FF8-BDBD-7DD450F86241

P932

Q35533708-7EF43257-D2CA-41E6-83CF-33AFF41F4931

P356

THORAX.55.4.289

P1433

P1476

A randomised controlled compar ...... e Dutch Tiotropium Study Group

@en

P2093

Bantje TA

http://www.w3.org/2001/XMLSchema#string

Cornelissen PJ

http://www.w3.org/2001/XMLSchema#string

Eland ME

http://www.w3.org/2001/XMLSchema#string

Korducki L

http://www.w3.org/2001/XMLSchema#string

van Noord JA

http://www.w3.org/2001/XMLSchema#string

P2860

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.

Value of serial peak expiratory flow measurements in assessing treatment response in chronic airflow limitation

Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials.

Relative contributions of large and small airways to flow limitation in normal subjects before and after atropine and isoproterenol.

Anticholinergic, antimuscarinic bronchodilators.

Muscarinic receptor subtypes in airways.

Relation between FEV1 and peak expiratory flow in patients with chronic airflow obstruction.

Ba 679 BR, a novel long-acting anticholinergic bronchodilator.

Effect of Ba 679 BR, a novel long-acting anticholinergic agent, on cholinergic neurotransmission in guinea pig and human airways.

P304

289-294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THORAX.55.4.289

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2000-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10722768

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

1745719

http://www.w3.org/2001/XMLSchema#string